SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc.
PVCT 0.06500.0%Nov 14 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mplaut who wrote (12169)7/3/2013 10:56:33 AM
From: NTTG1 Recommendation

Recommended By
Pogeu Mahone

  Read Replies (2) of 13111
 
At some point in time, small biotech companies need to put a stake in the ground and decide how they want to support their mission. The decision to go 'virtual' obligates the plan to a 'cash and carry' based pool of resources, no vested interest...poor quality performance. Wonder why it is taking so long to get to the next step with the FDA?

This is not a lean company when you consider compensation for productivity, it is actually quite bloated

If each FTE at PVCT had given up 55K of their 7 figure compensation, I dare say an outstanding 'regulatory' expert could have been found. Should have been a small potatoes decision for MGT, but then again, their plan has nothing to do with getting a drug through the development pipe, it is all about licensing and hoping the partner knows how to get the job done...

You can tell serious commitment by those kinds of decisions. PVCT is about protecting MGT pay

So investors wait and wait.......
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News